Navigation Links
PSA Can Predicts The Treatment Response In Advanced Prostate Cancer

A new study that has been conducted by researchers from the University of Michigan (U-M) medical school states that patients with lower PSA levels, //7 months after therapy lived longer.

According to a new multicentre study that has been conducted by the Southwest Oncology Group and led by researchers at the U-M Comprehensive Cancer Centre, that has been published in the August 20th issue of the Journal of Clinical Oncology, has explained that a test that is usually done to detect prostate cancer could also help doctors to know when the treatment is working. They further mentioned that the level of the prostate specific antigen, or PSA, in man after seven months of hormone therapy for advanced prostate cancer might foretell how long he would survive.

The study evaluated 1,345 men with prostate cancer that had spread to distant parts of the body. The men were treated with seven months of androgen deprivation therapy, a treatment designed to block the effects of hormones on the cancer. PSA levels were monitored throughout the treatment. The researchers found that men whose PSA dropped below 4.0 ng/ml had a quarter the risk of dying compared to those whose PSA was more than 4.0.

“Our analysis showed that a low or undetectable PSA after seven months of androgen deprivation therapy is a powerful predictor of risk of death in patients with new metastatic prostate cancer. This could allow oncologists to identify patients who are unlikely to do well with this treatment long before they develop clinical signs of treatment resistance,” says lead study author Maha Hussain, M.D., professor of internal medicine at the U-M Medical School.

The researchers found 69 percent of the men maintained a PSA level of less than 4.0 ng/ml after seven months of treatment and 43 percent had an undetectable level of PSA at that time. Patients whose PSA was higher than 4.0 at the end of seven months survived 13 months, while patients whose PSA drop
'"/>




Page: 1 2

Related medicine news :

1. Restricted Activity Predicts Disability
2. Fitness Level Predicts Stroke
3. Being Teased Predicts Poor Psychological Functioning in Youth With Cleft Lip
4. Model Predicts Colon Cancer Inheritable Genetic Defects
5. Formula Predicts Osteoporotic Fracture Risk
6. Computer Tool Predicts Effectiveness Of Microbicides
7. New Genetic Test Predicts Eye-Cancer Patients Futures
8. Technology Predicts Outcome of Child Heart Surgery
9. A Secret Dossier Predicts Major Changes At NHS, England
10. Activation of a Particular Brain Region Predicts Altruism: Study
11. New Test Predicts CLL’s Sensitivity to Experimental Drug
Post Your Comments:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...on to surgical treatment for rectal cancer may not... But the findings suggest that the radiation treat...tient's quality of life by reducing the rate of ca...l tumor site in the rectum. In about 15% to 45% of...
...dence of the disease was found to have been cut to...ressure in check. The study involving about 6,000 ...hat strokes were cut by at least a quarter among p...gs are inexpensive and easily available. Use of th...
...nd to support immunity in elderly, frail and patie...operation, rate of infection is a common risk, esp...searchers at the University of Pittsburgh report o...ch enhances the immune system in patients undergoi...
...e effects on the heart among the young and old.The...h have a diameter of less than ten micrometres. Th...n, by entering the circulation, especially in peop...ng to a new study by researchers at Harvard Univer...
Other Medicine News:
(Date:8/19/2008)... SAN DIEGO, Aug. 19 /-...ed a research collaboration with the Karolinska,In...d the Swedish Institute,for Infectious Disease Con...ate Vical,s Vaxfectin(R) adjuvant with the Bioject...edical Technologies Inc.,OTCBB:BJCT) for a multiv...
(Date:8/18/2008)... Study findings offer hope for increased life...GTON, Aug. 18 /PRNewswire-USNewswire/ -- In the wo...person whose progress has been,tracked for the pas... the,average life expectancy of a person with Down...he teens when ,Mr. C, was born. Further, ,Mr. C, d...
(Date:8/18/2008)... - Clinical trial currently in ... /- Tobira,Therapeutics Inc., a clini...esearch and product discovery against life-threate...announced the issuance of Patent No. 7,371,772,B2 ...the use of TBR-652, a,CCR5 antagonist currently in...
(Date:8/14/2008)... SINGAPORE, Aug. 15 /-...vative new partnership with the National Cancer,Ce...Hospital (NUH) to,develop anti-cancer compounds. T...um of Understanding (MOU) that was signed today, a...t capabilities in Asia and ultimately,speed up acc...
Breaking Medicine Technology:Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Finding the Right Home for Your Vitamins and Other Supplements 10672 1Finding the Right Home for Your Vitamins and Other Supplements 10672 2Finding the Right Home for Your Vitamins and Other Supplements 10672 3Psychotherapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars 10670 1Psychotherapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars 10670 2Conservation strategies must shift with global environmental change says CU Boulder study 2078 1Conservation strategies must shift with global environmental change says CU Boulder study 2078 2Environmental epigenetics has potential for preventing and treating disease 2076 1Environmental epigenetics has potential for preventing and treating disease 2076 2Environmental epigenetics has potential for preventing and treating disease 2076 3
.../PRNewswire-FirstCall/ - Oncolytics,Biotech Inc. a...al,work using reovirus in combination with gemcita...n for Cancer Research (AACR),website at <a target=... , and on the Oncolytics,website at <a target="_bl....oncolyticsbiotech.com .,The abstract is entitled ...
...SS WIRE)--Mar 14, 2007 - Researchers at,the Stanfo...led by,findings from their new study indicating th...ise in treating a behavioral disorder,known as com...fit,for the patients who took it., The medication ...ant sold under the brand name Lexapro. In the stud...
Other Medicine Technology:Oncolytics Biotech Inc. Collaborators to Present,Reovirus/Gemcitabine Combination Research at AACR Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present,Reovirus/Gemcitabine Combination Research at AACR Annual Meeting 3Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3
The DELFIA Platewash is a general purpose microtitration plate and strip washer especially standardized for use with DELFIA diagnostic kits.
SkanWasher 300 with a 25-microplate capacity stacker system. Vacuum pressure and aspiration and dispense probe heights are adjustable. On-board software for user to configure 8 different programs. Ex
...The Labcyte miniGene LW is a new plate washing sys... 96 and 384 channel microplates with flat, V-shape... with 8 or 16 channel nozzle heads. Simple LCD tou...tional plate stacker is available for the miniGene...
...Produce Up to 8000 L/day of Type III Laboratory-gr...ed to produce up to 8000 L/day of Type III laborat...omplete Purification and Control Unit, RiOs system...viding total control of all parameters within the ...
Medicine Products: